Invitrx Therapeutics, based in Irvine, California, is a pioneering clinical-stage life science company established in 2003. Originally focused on developing skin grafts for burn patients, Invitrx has since advanced to create a range of innovative cell therapy products for aesthetics, wound closure, plastic surgery, and reconstructive procedures.
Equipped with cutting-edge lab facilities and a commitment to quality and safety, Invitrx is dedicated to shaping a better future through its regenerative medicine technologies. Their products, including Cord Blood Stem Cell Products, Amniotic Fluid, and Wharton's Jelly, are designed for research use only, with safety practices overseen by IND and Clinical Trial IRB protocols.
Generated from the website